Next Article in Journal
Determinants of the Implementation of Human Papillomavirus Vaccination in Zambia: Application of the Consolidated Framework for Implementation Research
Next Article in Special Issue
Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries
Previous Article in Journal
Nanoparticles and Antiviral Vaccines
Previous Article in Special Issue
Mapping the Cognitive Biases Related to Vaccination: A Scoping Review of the Literature
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 12
Issue 1
10.3390/vaccines12010031
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0–6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies

by
Madina Abenova
1,
Askhat Shaltynov
1,
Ulzhan Jamedinova
1 and
Yuliya Semenova
2,*
1
Department of Biostatistics and Epidemiology, Semey Medical University, Semey 071400, Kazakhstan
2
School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan
*
Author to whom correspondence should be addressed.
Vaccines 2024, 12(1), 31; https://doi.org/10.3390/vaccines12010031
Submission received: 23 October 2023 / Revised: 13 December 2023 / Accepted: 14 December 2023 / Published: 27 December 2023
(This article belongs to the Special Issue Vaccine Hesitancy and Acceptance, Trends and Future Prospects for Public Health)
Browse Figures
Review Reports Versions Notes

Abstract

:
Routine vaccine hesitancy is a major global health challenge observed in over 190 countries worldwide. This meta-analysis aims to determine the worldwide prevalence of routine vaccination hesitancy among parents of children aged 0–6. An extensive search was conducted in four scientific databases: PubMed, Scopus, Web of Science, and the Cochrane Library. Studies were included if they reported hesitancy related to WHO-recommended routine immunizations for children under 7 years of age. A single-arm meta-analysis was performed using the OpenMeta[Analyst] software. An initial search retrieved 5121 articles, of which only 23 publications, involving 29,131 parents, guardians, and caregivers from over 30 countries met the inclusion criteria and quality assessment. The cumulative prevalence of parental vaccine hesitancy was found to be 21.1% (95% CI = 17.5–24.7%, I2 = 98.86%, p < 0.001). When stratifying the prevalence of vaccine hesitancy per WHO region, significant variations were observed, ranging from 13.3% (95% CI = 6.7–19.9%, I2 = 97.72%, p < 0.001) in the Region of the Americas to 27.9% (95% CI = 24.3–31.4%) in the Eastern Mediterranean region. The study findings highlight the need for healthcare providers and governments to develop and improve comprehensive programs with communication strategies to reduce parental vaccine hesitancy.

1. Introduction

Vaccine hesitancy, recognized by the World Health Organization (WHO), is a serious global problem, particularly as the incidence of infectious diseases among children rises. Public health services face numerous challenges in addressing this issue, including the impact of the COVID-19 pandemic, which has significantly affected parental confidence in vaccination [1,2]. Measles outbreaks occurring in various parts of the world also underscore the importance of monitoring and assessing the level of parental hesitancy regarding vaccinating children under 7 years of age [3,4,5]. This phenomenon, defined as the reluctance to promptly accept or refuse vaccination despite the widespread availability of vaccination services, poses a threat to global public health [6].
Although vaccinations help to prevent life-threatening infectious diseases, annually saving over 4 million lives, vaccination coverage rates continue to decline across the globe [7,8]. Recognizing the gravity of this issue, the WHO has designated a reduction in vaccine hesitancy as one of its foremost global priorities. Despite the significance of vaccine hesitancy, there are currently no universally effective interventions to address parental hesitancy and vaccine refusal [9].
Young children, especially infants and preschoolers, are at increased risk of illnesses and complications from infections that can be prevented by vaccination. According to the WHO recommendations, the following list of vaccines is recommended for all immunization programs worldwide in order to facilitate the development of optimal immunization schedules: Bacillus Calmette–Guérin (BCG) for tuberculosis, hepatitis B vaccine, polio vaccine, diphtheria, tetanus, and pertussis-containing vaccine (DTPCV), Haemophilus influenzae type b (Hib) vaccine, pneumococcal conjugate vaccine, rotavirus vaccine, measles vaccine, rubella vaccine, and human papillomavirus vaccine (HPV) [10]. According to the WHO-recommended immunization program, a significant portion of mandatory childhood immunization is administered before a child reaches the age of 7. This age category is the most suitable for assessing parental attitudes towards vaccination [11].
Vaccine hesitancy occurs in countries regardless of the varying levels of socioeconomic development. According to estimates, vaccine hesitancy is observed in over 190 countries worldwide, all of which are members of the WHO [12]. In a comprehensive retrospective study of 149 countries that analyzed global trends in vaccine confidence and included data from 284,381 individuals, it was found that confidence in the importance of vaccines exhibited the strongest univariate association with vaccination coverage [13]. Numerous research studies have aimed to identify parental hesitancy toward childhood vaccination [14,15,16,17,18,19]. Recent outbreaks of diseases preventable by vaccination have provided a stark reminder of the strong link between vaccine hesitancy and refusal. This highlights the importance of analyzing and monitoring the level of indecisiveness among parents, especially among parents of preschool-aged children [20,21].
Thus, this meta-analysis aims to synthesize data from various sources and use various assessment tools to create a more convincing, objective, and complete picture of the problem of parental hesitancy regarding compulsory childhood vaccination in general. Despite the presence of publications on the topic of indecision, no publications were identified that examined the general picture of indecision in parents of children under 7 years of age. Infants and young children are known to be more vulnerable to many infectious diseases. Identifying and understanding parental vaccine hesitancy in early childhood is critical to ensure the safety and health of children, prevent the spread of infections, and increase community confidence in vaccination. A subgroup analysis was conducted considering the type of data collection tool used, the world region, and the income level of the country.

2. Materials and Methods

2.1. Search Strategies

The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [22]. An extensive search was performed in four scientific databases: PubMed, Scopus, Web of Science, and Cochrane Library. Data were searched for from the date of database inception until 30 June 2023. The following combination of keywords was used: “parental vaccination hesitancy”, “vaccination hesitancy”, “routine vaccination hesitancy”, “child vaccination hesitancy”, “routine vaccination attitude”, “parental vaccination refusal”. “The following search strategy was applied in PubMed: (“parental” OR “caregiver” OR “guardians”) AND (“routine” OR “mandatory”) AND (“child” OR “children” OR “childhood”) AND (“vaccination” OR “immunization”) AND (“hesitancy” OR “attitude” OR “refusal”). Following that, we reviewed the abstracts and titles of all identified publications to ascertain if they satisfied the inclusion criteria. Subsequently, we examined the reference lists of all qualified articles to discover any pertinent articles.

2.2. Eligibility Criteria

To ensure the methodological quality of publications and adherence to the WHO-recommended list of vaccines for all immunization programs worldwide, inclusion and exclusion criteria were employed in the systematic review of articles. This was done to calculate the prevalence of hesitancy among parents, caregivers, and guardians (Table 1).

2.3. Data Extraction

In the first stage of the study, the first author of the present review (M.B.) imported all identified studies from databases into the Rayyan.ai web platform [23] to identify and remove duplicates. In the second stage, after removing duplicates, M.B. and A.S. independently conducted initial screenings of study titles and abstracts. All studies that did not meet the inclusion criteria were excluded from the study. During the secondary screening, full-text articles were assessed against the inclusion criteria. Articles that passed the two stages of screening were entered into a data extraction sheet. All additional questions and discrepancies regarding the acceptability of articles were resolved through discussion with another researcher (Yu.S.). The process of selection in accordance with PRISMA guidelines is presented in Figure 1. The following data were recorded for each study: author, year of publication, country, study period, type of study, sample size, targeted population, data collection tool, and vaccine hesitancy/refusal/delay rate.

2.4. Quality Assessment

The Joanna Briggs Institute (JBI) checklist is a standardized and widely used tool for assessing research quality, developed by the Joanna Briggs Institute [24]. It comprises a set of questions or criteria reflecting the key elements of a well-planned study, including studies with cross-sectional study designs. This tool enables the evaluation of studies by providing 4 response options: “yes”, “no”, “unclear”, and “not available”. Articles were categorized into three quality groups: low quality (scoring 1 and 2 out of 9), moderate quality (scoring 3–6 out of 9), and high quality (scoring 7–9) [24]. Only studies demonstrating high methodological quality, scoring 7 and above on the JBI checklist, were considered in this review.

2.5. Statistical Analyses

A single-arm meta-analysis was conducted using the OpenMeta[Analyst] software, which had been developed at Brown University in Providence, Rhode Island, United States [25]. ArcMap v.10.8.1 by ESRI, produced in Redlands, California, United States [26], was employed to perform the mapping of the included studies. The prevalence of vaccine hesitancy was determined using the random effects model and the restricted maximum likelihood method, incorporating 95% confidence intervals (CIs). The assessment of the heterogeneity level was carried out using the I2 statistic test. I2 values below 25% were indicative of low heterogeneity, while values between 25% and 75% suggested moderate heterogeneity, and values exceeding 75% indicated high heterogeneity [25]. To calculate a weight based on the sample sizes of the studies, vaccine hesitancy rates from both the multi-country study with multiple outcomes and the vaccine hesitancy study at three time points were entered separately into the analysis. Subgroup analyses were undertaken when prevalence data were subdivided into categories based on World Bank country classifications by income level [27], data collection tool, and world region [28].

3. Results

3.1. Overview of Included Studies

Searches across four databases (PubMed, Scopus, Web of Science, Cochrane Library) retrieved a total of 5121 articles. Out of these, only 23 met the inclusion/exclusion criteria and passed the quality assessment. These 23 studies involved 29,131 parents, guardians, and caregivers of children aged 0–6 years (see Table 1). The studies originated from various countries, including Italy, India, the USA, Canada, Turkey, Austria, Bulgaria, Croatia, Cyprus, Germany, Greece, Hungary, Israel, Lithuania, Malta, Moldova, the Netherlands, Poland, Portugal, Slovenia, Spain, Ukraine, Pakistan, Cameroon, Ethiopia, China, France, the Philippines, Brazil, England, and Malaysia. In several countries, multiple studies were conducted, with Italy having three studies, India having five studies, Turkey having three studies, and Brazil having two studies. The earliest study was carried out in Canada from March 2014 to February 2015, while the latest study was conducted in Turkey from September to December 2021. Sample sizes across the studies ranged from 99 to 3130 parents.
Five different assessment tools were employed in the included articles: Parent Attitudes About Childhood Vaccines (PACV), WHO Strategic Advisory Group of Experts Vaccine Hesitancy Scale (WHO SAGE VHS), a combination of both PACV and WHO SAGE VHS, Vaccine Confidence Index (VCI), and a self-structured questionnaire. The PACV questionnaire was applied in seven studies, encompassing a total of 5694 parents/caregivers in the countries of Italy [29], India [30,31], the USA [32], Canada [33], and Turkey [34,35,36]. The highest number of studies utilized the WHO SAGE VHS, with eight studies involving a sample size of 10,417 parents/caregivers from Pakistan [37], India [38,39], Cameroon [40], Ethiopia [41], China [42], France [43], and the Philippines [44]. A study conducted across 18 European countries employed a survey based on two sources, PACV and WHO SAGE VHS, with the participation of 5736 parents/caregivers [45]. Self-administered questionnaires were applied in Brazil [46], England [47], India [48], Italy [49], and Malaysia [50], involving 6938 parents/caregivers. The Vaccine Confidence Index (VCI) was used in Brazil [51], involving 952 parents, of whom 352 were parents of children under 5 years of age. Out of the 32 countries examined in the study [29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51], 21 studies were carried out in countries categorized as high-income by the World Bank, 11 studies in upper-middle-income countries, 9 studies in lower-middle-income countries, and 1 study in a low-income country, specifically Ethiopia. Table 2 provides an overview of the characteristics of all the studies included in the meta-analysis. Figure 2 depicts a world map showing the countries included in the systematic review.

3.2. Cumulative Prevalence

In accordance with a meta-analysis of 23 articles, the cumulative prevalence of vaccine hesitancy among parents of children aged 0–6 years was 21.1% (95% CI = 17.5–24.7%, I2 = 98.86%, p < 0.001) (Figure 3).

3.3. Subgroup Analyses

When stratifying the prevalence of vaccine hesitancy by the type of questionnaire used across different studies, the prevalence of vaccination hesitancy ranged from 12.7% (95% CI = 4.5–20.9%, I2 = 99.21%, p < 0.001) when VCI was used to 27.1% (95% CI = 22.3–31.9%, I2 = 94.78%, p < 0.001) when PACV and WHO SAGE VHS were used (Figure 4).
The prevalence of vaccine hesitancy among parents of children aged 0–6 years varied across countries with different income levels. In lower-middle-income countries, it ranged from 3.4% (95% CI = 0.7–6.2%) [31] to 41.6% (95% CI = 39.2–44%) [39] in India. In upper-middle-income countries, it ranged from 5% (95% CI = 3.8–6.2%) in Brazil [46] to 34.9% (95% CI = 30.6–39.1%) in Bulgaria [45]. In high-income countries, the cumulative prevalence was 22.5% (95% CI = 17.8–27.2%, I2 = 98.21%, p < 0.001), with rates ranging from 7.7% (95% CI = 5.5–9.8%) in Italy [29] to 41.8% (95% CI = 34.8–48.7%) in Israel [45]. In Ethiopia, the prevalence of vaccine hesitancy was found to be 3.4% (95% CI = 1.5–5.3%) [41] (Figure 5).
The prevalence of parental vaccine hesitancy for child routine vaccinations, as per the WHO region, exhibited a variation in findings, with a cumulative rate of 14.6%. This range spans from 13.3% (95% CI = 6.7–19.9%, I2 = 97.72%, p < 0.001) in the Region of the Americas to 27.9% (95% CI = 24.3–31.4%) in the Eastern Mediterranean region (Figure 6).

4. Discussion

Combining various studies into a unified analysis will yield a deeper and more comprehensive understanding of parental hesitancy toward routine vaccination. This can be pivotal in crafting targeted programs to enhance awareness and increase vaccination rates among children. Previous systematic reviews have often noted the lack of a single indicator capable of effectively measuring parental vaccine hesitancy. Therefore, we conducted this systematic review and meta-analysis of cross-sectional studies to determine the overall rate of hesitancy among parents or caregivers regarding mandatory vaccination for children under 7 years of age. Our meta-analysis revealed a cumulative prevalence of parental vaccine hesitancy at 21.1% (95% CI = 17.5–24.7%), which was statistically significant (p < 0.001). However, we observed a high level of heterogeneity (I2 = 98.86%), signifying variations in the study outcomes included in the analysis, potentially distorting the assessment of the mean effect across studies. To address this heterogeneity and mitigate its impact on result interpretation, subgroup analyses were performed based on income level [27], data collection tools, and world region. Several potential reasons for this heterogeneity were identified, including differences in defining vaccine hesitancy, variations in tools used for its measurement, disparities in income levels among countries, and discrepancies in approved vaccination schedules. Moreover, differences in parental hesitancy toward childhood vaccination in countries such as high-income countries may be due to increased access to information and resources that allow parents to be more informed about vaccination decisions and choices. In addition, high levels of education and diversity of opinions and perspectives in society may also contribute to a greater diversity of views on vaccination among parents. This may lead to greater heterogeneity in decisions about childhood vaccinations, which in turn may affect the level of hesitancy among parents. However, the presence of these factors, in varying proportions, may be individual for each country or society [53,54].
According to the definition provided by the Strategic Advisory Group of Experts (SAGE) Working Group on Vaccine Hesitancy (VH), vaccine hesitancy (VH) refers to the delay in acceptance or refusal of vaccination despite the availability of vaccination services [1]. However, different studies interpret this definition in various ways. Some studies solely focus on refusal rates and delayed or incomplete vaccination and do not employ a specific tool to identify hesitancy rates. Various questionnaires have been developed and are used to assess vaccine hesitancy. The diversity in definitions and assessment tools of vaccine hesitancy can lead to ambiguous result interpretations, complicating comparisons and comparability. The inability to compare datasets can result in information loss or incorrect amalgamation. Therefore, a unified strategy with stringent inclusion and exclusion criteria for studies is a crucial and necessary aspect for synthesizing results in future review articles.
This meta-analysis covers five different tools for evaluating parental vaccine hesitancy: the Parent Attitudes About Childhood Vaccines (PACV), the WHO SAGE Vaccine Hesitancy Scale (VHS), a combination of both PACV and WHO SAGE VHS, the Vaccine Confidence Index (VCI), and a self-structured questionnaire. The PACV questionnaire was originally developed by Opel et al. [7], while the SAGE VHS was formulated under the guidance of the WHO by Larson et al. in 2015 [1]. Another tool in use is the VCI, which comprises three questions designed for the global assessment of vaccine confidence. One of the largest recent questionnaires in this area is “The Vaccine Confidence Project” [12], which collected 65,819 responses across 67 countries [37]. Additionally, the 5C+ Model, used to measure vaccine hesitancy, incorporates dimensions such as confidence, complacency, constraints, calculation, and collective responsibility, particularly in relation to identifying psychological barriers to vaccination behavior. Valid instruments for assessing adherence [38] and willingness [39] for these vaccines are also available. However, our objective did not encompass these factors, and the studies we scrutinized primarily investigated hesitancy concerning childhood vaccinations.
It is important to acknowledge the diversity of vaccination schedules approved by different countries. To consolidate the findings and calculate a global vaccine hesitancy (VH) rate, this meta-analysis focused solely on the vaccines recommended by the WHO for global immunization programs. Consequently, we excluded studies that reported unified vaccine coverage rates for the routine WHO immunization program along with one or more additional vaccines. This exclusion criterion led to the removal of certain studies, including the one by Ngandjon et al. (2022) that examined yellow fever vaccine hesitancy alongside other mandatory vaccinations [40], the study by Napolitano et al. (2018) that assessed varicella vaccine hesitancy [41], and the study by Dasgupta et al. (2018) that explored Japanese encephalitis vaccine hesitancy rates [55]. We do not discount the possibility of excluding a significant portion of studies from the meta-analysis due to the stringent inclusion and exclusion criteria employed in the study. However, applying this methodology enables us to identify generalized outcomes regarding parental hesitancy towards routine vaccination.
Reasons for VH vary according to geographic location, the economic status of the country, and the type of vaccination. According to Obohwemu et al. (2022), unfavorable attitudes and behavioral tendencies towards vaccination, such as reduced perceptions of vaccine effectiveness and mistrust of health authorities, were the most common barriers to vaccine uptake. The main determinants of VH include confidence and complacency, which encompass anxiety, a low perceived risk, a low severity of the disease, reduced confidence in the safety and effectiveness of vaccines, a lack of trust in healthcare providers and vaccination services, and fear of side effects [56]. Misinformation on various media platforms and lack of knowledge are some of the reasons for vaccine refusals in many countries [57]. Despite the significance of vaccine hesitancy, there are currently no universally effective measures to eliminate parental hesitancy and vaccine refusal [9]. Public health services face numerous challenges in addressing this problem, including the impact of the COVID-19 pandemic, which has played a significant role in shaping parental confidence in vaccination. Current measles outbreaks around the world also highlight the importance of monitoring and measuring VH among parents of children aged under 7 years [5]. Various countries actively employ comprehensive programs aimed at enhancing public knowledge and awareness through mass media utilization and training healthcare workers in communication tools. Interventions based on vaccination reminders are also employed to combat vaccine hesitancy [58,59]. Considering the widespread prevalence of parental hesitancy toward childhood vaccination in different countries, as supported by research findings, there is a need to continually refine existing strategies to reduce parental hesitancy levels regarding mandatory childhood vaccination, especially among preschool-aged children.
This work has several limitations that should be acknowledged. Firstly, a high degree of heterogeneity among the studies included in this meta-analysis was identified. Variations in the definitions of VH across studies; the wide range of tools for detecting VH, income levels of the countries, and world regions; and disparities in approved vaccination schedules could contribute to the heterogeneity of the data. However, we mitigated these concerns by implementing rigorous inclusion and exclusion criteria for articles, as well as employing a validated tool for assessing publication quality, allowing us to exclude studies of low to moderate methodological quality. Second, the cross-sectional study design does not allow for the determination of cause-and-effect relationships in the studies. Third, we excluded studies not written in English, non-full-text articles, conference abstracts, and government reports. Given the substantial heterogeneity observed in studies, future research could address these limitations by adopting a unified vaccination schedule recommended by the World Health Organization for all countries in systematic reviews examining vaccine hesitancy in children. Additionally, conducting high-quality research is advised to identify the causal relationships existing with parental hesitancy regarding mandatory childhood vaccination.
To the best of our knowledge, this is the first meta-analysis aimed at analyzing VH among parents of children under 7 years of age. This age group of children is often at a higher risk of contracting infectious diseases due to their developing immune systems [8]. In this study, we did not include HPV hesitancy in the analysis for two reasons: the timing of HPV vaccination (typically administered over the age of 7) and the likely differences in the nature of hesitancy related to HPV vaccination compared to routine childhood vaccinations. The study has several strengths, including extensive coverage, independent screening, and bias control. It also utilizes a validated research quality assessment tool. Despite not having restrictions on the year of publication, the studies included in the review had a research depth of less than 10 years (from 2014 to 2021).

5. Conclusions

In this meta-analysis, the cumulative prevalence of parental vaccine hesitancy was determined to be 21.1% (95% CI = 17.5–24.7%, I2 = 98.86%, p < 0.001). While this meta-analysis included studies from over 30 different countries, it is important to note that this prevalence may not fully represent the global parental vaccine hesitancy rate. Nevertheless, identifying a pooled vaccine hesitancy rate can provide a consistent approach for monitoring and analyzing trends in vaccine hesitancy worldwide. This, in turn, could contribute to the development and enhancement of comprehensive programs with communication strategies for healthcare institutions and governments aimed at reducing parental vaccine hesitancy, ultimately leading to increased vaccination coverage and strengthened protection against vaccine-preventable diseases. Future research efforts should prioritize the development of a comprehensive indicator to assess parental vaccine hesitancy, taking into account the complexities and variations observed in our study.

Author Contributions

Conceptualization: M.A. and Y.S.; methodology and analysis: M.A., A.S. and U.J.; formal analysis: M.A. and U.J.; visualization: M.A.; writing—original draft preparation: M.A. and A.S.; writing—review and editing: M.A., Y.S., A.S. and U.J.; supervision: Y.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (Grant No. AP15473448). The funding source had no involvement in the study.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data supporting this systematic review are available in the reference section. In addition, the analyzed data used in this systematic review are available from the author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Olusanya, O.A.; Bednarczyk, R.A.; Davis, R.L.; Shaban-Nejad, A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front. Immunol. 2021, 12, 663074. [Google Scholar] [CrossRef] [PubMed]
  2. Dong, Y.; Wang, L.; Burgner, D.P.; Miller, J.E.; Song, Y.; Ren, X.; Li, Z.; Xing, Y.; Ma, J.; Sawyer, S.M.; et al. Infectious Diseases in Children and Adolescents in China: Analysis of National Surveillance Data from 2008 to 2017. BMJ 2020, 369, m1043. [Google Scholar] [CrossRef] [PubMed]
  3. Porter, A.; Goldfarb, J. Measles: A Dangerous Vaccine-Preventable Disease Returns. Cleve. Clin. J. Med. 2019, 86, 393–398. [Google Scholar] [CrossRef] [PubMed]
  4. Siani, A. Measles Outbreaks in Italy: A Paradigm of the Re-Emergence of Vaccine-Preventable Diseases in Developed Countries. Prev. Med. 2019, 121, 99–104. [Google Scholar] [CrossRef] [PubMed]
  5. Measles. Available online: https://www.who.int/news-room/fact-sheets/detail/measles (accessed on 16 October 2023).
  6. MacDonald, N.E.; Eskola, J.; Liang, X.; Chaudhuri, M.; Dube, E.; Gellin, B.; Goldstein, S.; Larson, H.; Manzo, M.L.; Reingold, A.; et al. Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef] [PubMed]
  7. Охват Иммунизацией [Immunization Coverage]. Available online: https://www.who.int/ru/news-room/fact-sheets/detail/immunization-coverage (accessed on 16 June 2022).
  8. Vaccines and Immunization: What Is Vaccination? Available online: https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination (accessed on 11 October 2023).
  9. Sadaf, A.; Richards, J.L.; Glanz, J.; Salmon, D.A.; Omer, S.B. A Systematic Review of Interventions for Reducing Parental Vaccine Refusal and Vaccine Hesitancy. Vaccine 2013, 31, 4293–4304. [Google Scholar] [CrossRef]
  10. Immunization, Vaccines and Biologicals. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization---summary-tables (accessed on 11 October 2023).
  11. Chan, P.S.-F.; Fang, Y.; Kawuki, J.; Chen, S.; Liang, X.; Mo, P.K.-H.; Wang, Z. Parental Acceptance, Parental Hesitancy, and Uptake of Seasonal Influenza Vaccination among Children Aged 6-59 Months: A Systematic Review and Meta-Analysis. Vaccines 2023, 11, 1360. [Google Scholar] [CrossRef]
  12. Lane, S.; MacDonald, N.E.; Marti, M.; Dumolard, L. Vaccine Hesitancy around the Globe: Analysis of Three Years of WHO/UNICEF Joint Reporting Form Data-2015–2017. Vaccine 2018, 36, 3861–3867. [Google Scholar] [CrossRef]
  13. de Figueiredo, A.; Simas, C.; Karafillakis, E.; Paterson, P.; Larson, H.J. Mapping Global Trends in Vaccine Confidence and Investigating Barriers to Vaccine Uptake: A Large-Scale Retrospective Temporal Modelling Study. Lancet 2020, 396, 898–908. [Google Scholar] [CrossRef]
  14. Opel, D.J.; Mangione-Smith, R.; Taylor, J.A.; Korfiatis, C.; Wiese, C.; Catz, S.; Martin, D.P. Development of a Survey to Identify Vaccine-Hesitant Parents: The Parent Attitudes about Childhood Vaccines Survey. Hum. Vaccin. 2011, 7, 419–425. [Google Scholar] [CrossRef]
  15. Wagner, A.L.; Masters, N.B.; Domek, G.J.; Mathew, J.L.; Sun, X.; Asturias, E.J.; Ren, J.; Huang, Z.; Contreras-Roldan, I.L.; Gebremeskel, B.; et al. Comparisons of Vaccine Hesitancy across Five Low- and Middle-Income Countries. Vaccines 2019, 7, 155. [Google Scholar] [CrossRef] [PubMed]
  16. Choudhary, T.S.; Reddy, N.S.; Apte, A.; Sinha, B.; Roy, S.; Nair, N.P.; Sindhu, K.N.; Patil, R.; Upadhyay, R.P.; Chowdhury, R. Delayed Vaccination and Its Predictors among Children under 2 Years in India: Insights from the National Family Health Survey-4. Vaccine 2019, 37, 2331–2339. [Google Scholar] [CrossRef] [PubMed]
  17. Ren, J.; Wagner, A.L.; Zheng, A.; Sun, X.; Boulton, M.L.; Huang, Z.; Zikmund-Fisher, B.J. The Demographics of Vaccine Hesitancy in Shanghai, China. PLoS ONE 2018, 13, e0209117. [Google Scholar] [CrossRef] [PubMed]
  18. Dubé, E.; Gagnon, D.; Nickels, E.; Jeram, S.; Schuster, M. Mapping Vaccine Hesitancy—Country-Specific Characteristics of a Global Phenomenon. Vaccine 2014, 32, 6649. [Google Scholar] [CrossRef] [PubMed]
  19. Jafflin, K.; Deml, M.J.; Schwendener, C.L.; Kiener, L.; Delfino, A.; Gafner, R.; Schudel, S.; Mäusezahl, M.; Berger, C.; Huber, B.M.; et al. Parental and Provider Vaccine Hesitancy and Non-Timely Childhood Vaccination in Switzerland. Vaccine 2022, 40, 3193–3202. [Google Scholar] [CrossRef] [PubMed]
  20. Phadke, V.K.; Bednarczyk, R.A.; Salmon, D.A.; Omer, S.B. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA 2016, 315, 1149–1158. [Google Scholar] [CrossRef] [PubMed]
  21. Dubé, E.; Vivion, M.; MacDonald, N.E. Vaccine Hesitancy, Vaccine Refusal and the Anti-Vaccine Movement: Influence, Impact and Implications. Expert Rev. Vaccines 2015, 14, 99–117. [Google Scholar] [CrossRef]
  22. PRISMA. Available online: http://www.prisma-statement.org/?AspxAutoDetectCookieSupport=1 (accessed on 11 October 2023).
  23. Rayyan—AI Powered Tool for Systematic Literature Reviews. Available online: https://www.rayyan.ai/ (accessed on 1 December 2023).
  24. JBI Critical Appraisal Tools. JBI. Available online: https://jbi.global/critical-appraisal-tools (accessed on 11 October 2023).
  25. OpenMeta [Analyst]—CEBM @ Brown. Available online: http://www.cebm.brown.edu/openmeta/ (accessed on 11 October 2023).
  26. ArcMap Resources for ArcGIS Desktop. Documentation, Tutorials & More. Available online: https://www.esri.com/en-us/arcgis/products/arcgis-desktop/resources (accessed on 11 October 2023).
  27. New World Bank Country Classifications by Income Level: 2022–2023. Available online: https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2022-2023 (accessed on 11 October 2023).
  28. Countries. World Health Organization. Available online: https://www.who.int/countries (accessed on 11 October 2023).
  29. Bianco, A.; Mascaro, V.; Zucco, R.; Pavia, M. Parent Perspectives on Childhood Vaccination: How to Deal with Vaccine Hesitancy and Refusal? Vaccine 2019, 37, 984–990. [Google Scholar] [CrossRef]
  30. Sahoo, S.S.; Parida, S.P.; Singh, A.K.; Palepu, S.; Sahoo, D.P.; Bhatia, V. Decision-Making in Childhood Vaccination: Vaccine Hesitancy among Caregivers of under-5 Children from a Tertiary Care Institution in Eastern India. Ther. Adv. Vaccines Immunother. 2023, 11, 25151355231152650. [Google Scholar] [CrossRef]
  31. Kumar, N.; Thapar, R.; Surendran, P.; Shahdiya, A.; Mahendran, V.; Ramesh, R.; Shetty, D.J.; Unnikrishnan, B.; Mithra, P.; Holla, R.; et al. Vaccine Hesitancy among Mothers of Under-Five Children in Coastal South India: A Facility-Based Cross-Sectional Study. F1000Research 2021, 10, 186. [Google Scholar] [CrossRef]
  32. Williams, J.T.B.; Rice, J.D.; Lou, Y.; Bayliss, E.A.; Federico, S.G.; Hambidge, S.J.; O’Leary, S.T. Parental Vaccine Hesitancy and Vaccination Disparities in a Safety-Net System. Pediatrics 2021, 147, 2020010710. [Google Scholar] [CrossRef]
  33. Dubé, È.; Farrands, A.; Lemaitre, T.; Boulianne, N.; Sauvageau, C.; Boucher, F.D.; Tapiero, B.; Quach, C.; Ouakki, M.; Gosselin, V.; et al. Overview of Knowledge, Attitudes, Beliefs, Vaccine Hesitancy and Vaccine Acceptance among Mothers of Infants in Quebec, Canada. Hum. Vaccin. Immunother. 2019, 15, 113. [Google Scholar] [CrossRef] [PubMed]
  34. Ustuner Top, F.; Çevik, C.; Bora Güneş, N. The Relation between Digital Literacy, Cyberchondria, and Parents’ Attitudes to Childhood Vaccines. J. Pediatr. Nurs. Nurs. Care Child. Fam. 2023, 70, 12–19. [Google Scholar] [CrossRef] [PubMed]
  35. Yörük, S.; Güler, D. Factors Associated with Pediatric Vaccine Hesitancy of Parents: A Cross-Sectional Study in Turkey. Hum. Vaccin. Immunother. 2021, 17, 4505. [Google Scholar] [CrossRef] [PubMed]
  36. Durmaz, N.; Suman, M.; Ersoy, M.; Örün, E. Parents’ Attitudes toward Childhood Vaccines and COVID-19 Vaccines in a Turkish Pediatric Outpatient Population. Vaccines 2022, 10, 1958. [Google Scholar] [CrossRef] [PubMed]
  37. Khattak, F.A.; Rehman, K.; Shahzad, M.; Arif, N.; Ullah, N.; Kibria, Z.; Arshad, M.; Afaq, S.; Ibrahimzai, A.K.; Haq, Z.U. Prevalence of Parental Refusal Rate and Its Associated Factors in Routine Immunization by Using WHO Vaccine Hesitancy Tool: A Cross Sectional Study at District Bannu, KP, Pakistan. Int. J. Infect. Dis. 2021, 104, 117–124. [Google Scholar] [CrossRef] [PubMed]
  38. Goruntla, N.; Akanksha, K.; Lalithaasudhaa, K.; Pinnu, V.; Jinka, D.; Bhupalam, P.; Doniparthi, J. Prevalence and Predictors of Vaccine Hesitancy among Mothers of Under-Five Children: A Hospital-Based Cross-Sectional Study. J. Educ. Health Promot. 2023, 12, 34. [Google Scholar] [CrossRef] [PubMed]
  39. Ghosh, A.; Annigeri, S.; Kumar Hemram, S.; Kumar Dey, P.; Mazumder, S.; Ghosh, P. Demography and Determinants of Incomplete Immunization in Children Aged 1–5 Years and Vaccine-Hesitancy among Caregivers: An Eastern Indian Perspective. Clin. Epidemiol. Glob. Health 2022, 17, 101155. [Google Scholar] [CrossRef]
  40. Yakum, M.N.; Funwie, A.D.; Ajong, A.B.; Tsafack, M.; Ze, L.E.E.; Shah, Z. The Burden of Vaccine Hesitancy for Routine Immunization in Yaounde-Cameroon: A Cross-Sectional Study. PLoS Glob. Public Health 2022, 2, e0001012. [Google Scholar] [CrossRef]
  41. Masters, N.B.; Tefera, Y.A.; Wagner, A.L.; Boulton, M.L. Vaccine Hesitancy among Caregivers and Association with Childhood Vaccination Timeliness in Addis Ababa, Ethiopia. Hum. Vaccines Immunother. 2018, 14, 2340–2347. [Google Scholar] [CrossRef]
  42. Wang, Z.; Chen, S.; Fang, Y. Parental Willingness and Associated Factors of Pediatric Vaccination in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Vaccines 2022, 10, 1453. [Google Scholar] [CrossRef] [PubMed]
  43. Bocquier, A.; Fressard, L.; Cortaredona, S.; Zaytseva, A.; Ward, J.; Gautier, A.; Peretti-Watel, P.; Verger, P. Social Differentiation of Vaccine Hesitancy among French Parents and the Mediating Role of Trust and Commitment to Health: A Nationwide Cross-Sectional Study. Vaccine 2018, 36, 7666–7673. [Google Scholar] [CrossRef] [PubMed]
  44. Migriño, J.; Gayados, B.; Birol, K.R.J.; De Jesus, L.; Lopez, C.W.; Mercado, W.C.; Tolosa, J.M.C.; Torreda, J.; Tulagan, G. Factors Affecting Vaccine Hesitancy among Families with Children 2 Years Old and Younger in Two Urban Communities in Manila, Philippines. West. Pacific Surveill. Response J. WPSAR 2020, 11, 20. [Google Scholar] [CrossRef] [PubMed]
  45. Hadjipanayis, A.; van Esso, D.; del Torso, S.; Dornbusch, H.J.; Michailidou, K.; Minicuci, N.; Pancheva, R.; Mujkic, A.; Geitmann, K.; Syridou, G.; et al. Vaccine Confidence among Parents: Large Scale Study in Eighteen European Countries. Vaccine 2020, 38, 1505–1512. [Google Scholar] [CrossRef] [PubMed]
  46. Neto, J.O.; Olbrich, S.R.L.R. Attitudes, Hesitancy, Concerns, and Inconsistencies Regarding Vaccines Reported by Parents of Preschool Children. Rev. Paul. Pediatr. 2023, 41, e2022009. [Google Scholar] [CrossRef] [PubMed]
  47. Campbell, H.; Edwards, A.; Letley, L.; Bedford, H.; Ramsay, M.; Yarwood, J. Changing Attitudes to Childhood Immunisation in English Parents. Vaccine 2017, 35, 2979–2985. [Google Scholar] [CrossRef] [PubMed]
  48. Cherian, V.; Saini, N.K.; Sharma, A.K.; Philip, J. Prevalence and Predictors of Vaccine Hesitancy in an Urbanized Agglomeration of New Delhi, India. J. Public Health 2022, 44, 70–76. [Google Scholar] [CrossRef]
  49. Giambi, C.; Fabiani, M.; D’Ancona, F.; Ferrara, L.; Fiacchini, D.; Gallo, T.; Martinelli, D.; Pascucci, M.G.; Prato, R.; Filia, A.; et al. Parental Vaccine Hesitancy in Italy—Results from a National Survey. Vaccine 2018, 36, 779–787. [Google Scholar] [CrossRef]
  50. Voo, J.Y.H.; Lean, Q.Y.; Ming, L.C.; Hanafiah, N.H.M.; Al-Worafi, Y.M.; Ibrahim, B. Vaccine Knowledge, Awareness and Hesitancy: A Cross Sectional Survey among Parents Residing at Sandakan District, Sabah. Vaccines 2021, 9, 1348. [Google Scholar] [CrossRef]
  51. Brown, A.L.; Sperandio, M.; Turssi, C.P.; Leite, R.M.A.; Berton, V.F.; Succi, R.M.; Larson, H.; Napimoga, M.H. Vaccine Confidence and Hesitancy in Brazil. Cad. Saude Publica 2018, 34, e00011618. [Google Scholar] [CrossRef]
  52. Wang, Q.; Xiu, S.; Yang, L.; Han, Y.; Cui, T.; Shi, N.; Liu, M.; Yi, Y.; Liu, C.; Wang, X.; et al. Changes in Parental Attitudes Toward COVID-19 Vaccination and Routine Childhood Vaccination During the COVID-19 Pandemic: Repeated Cross-Sectional Survey Study. JMIR Public Health Surveill. 2022, 8, e33235. [Google Scholar] [CrossRef] [PubMed]
  53. Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef] [PubMed]
  54. Moradpour, J.; Shajarizadeh, A.; Carter, J.; Chit, A.; Grootendorst, P. The Impact of National Income and Vaccine Hesitancy on Country-Level COVID-19 Vaccine Uptake. PLoS ONE 2023, 18, e0293184. [Google Scholar] [CrossRef] [PubMed]
  55. Dasgupta, P.; Bhattacherjee, S.; Mukherjee, A.; Dasgupta, S. Vaccine Hesitancy for Childhood Vaccinations in Slum Areas of Siliguri, India. Indian J. Public Health 2018, 62, 253–258. [Google Scholar] [CrossRef] [PubMed]
  56. Obohwemu, K.; Christie-De Jong, F.; Ling, J. Parental Childhood Vaccine Hesitancy and Predicting Uptake of Vaccinations: A Systematic Review. Prim. Health Care Res. Dev. 2022, 23, e68. [Google Scholar] [CrossRef]
  57. Dyda, A.; King, C.; Dey, A.; Leask, J.; Dunn, A.G. A Systematic Review of Studies That Measure Parental Vaccine Attitudes and Beliefs in Childhood Vaccination. BMC Public Health 2020, 20, 1253. [Google Scholar] [CrossRef]
  58. Kaufman, J.; Ryan, R.; Walsh, L.; Horey, D.; Leask, J.; Robinson, P.; Hill, S. Face-to-Face Interventions for Informing or Educating Parents about Early Childhood Vaccination. Cochrane Database Syst. Rev. 2018, 5. [Google Scholar] [CrossRef]
  59. Jarrett, C.; Wilson, R.; O’Leary, M.; Eckersberger, E.; Larson, H.J.; Eskola, J.; Liang, X.; Chaudhuri, M.; Dube, E.; Gellin, B.; et al. Strategies for Addressing Vaccine Hesitancy—A Systematic Review. Vaccine 2015, 33, 4180–4190. [Google Scholar] [CrossRef]
Vaccines 12 00031 g001
Figure 1. PRISMA flowchart indicating the process of study identification, screening, and inclusion.
Figure 1. PRISMA flowchart indicating the process of study identification, screening, and inclusion.
Vaccines 12 00031 g001
Vaccines 12 00031 g002
Figure 2. Map of included studies (n = 23) examining the prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years (n = 29,131) [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Figure 2. Map of included studies (n = 23) examining the prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years (n = 29,131) [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Vaccines 12 00031 g002
Vaccines 12 00031 g003
Figure 3. Forest plot of studies (n = 23) examining the prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years (n = 29,131) [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Figure 3. Forest plot of studies (n = 23) examining the prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years (n = 29,131) [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Vaccines 12 00031 g003
Vaccines 12 00031 g004
Figure 4. Forest plot of prevalence child routine vaccination hesitancy of parents children aged 0–6 years depending on the data collection tool [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Figure 4. Forest plot of prevalence child routine vaccination hesitancy of parents children aged 0–6 years depending on the data collection tool [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Vaccines 12 00031 g004
Vaccines 12 00031 g005
Figure 5. Forest plot of prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years depending on the income level of a country [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Figure 5. Forest plot of prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years depending on the income level of a country [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Vaccines 12 00031 g005
Vaccines 12 00031 g006
Figure 6. Forest plot of prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years depending on the world region [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Figure 6. Forest plot of prevalence of child routine vaccination hesitancy among parents of children aged 0–6 years depending on the world region [29,30,31,32,33,34,35,36,37,38,39,40,41,43,44,45,46,47,48,49,50,51,52].
Vaccines 12 00031 g006
Table 1. Inclusion and exclusion criteria based on the provided information.
Table 1. Inclusion and exclusion criteria based on the provided information.
Inclusion CriteriaExclusion Criteria
  • Language of publication: English
1. Validation, testing, or adaptation of questionnaires
2.
Studies examining the prevalence of hesitancy among parents, caregivers, and guardians of healthy children under 7 years of age
2. Studies involving expectant parents’ vaccine hesitancy
3.
Inclusion criterion related to parental hesitancy regarding WHO-recommended routine immunizations for children under 7 years old. These vaccines include BCG, hepatitis B, polio, DTP-containing vaccine, Haemophilus influenzae type b (Hib), pneumococcal (conjugate), rotavirus, measles, and rubella [8]
3. Research designs other than cross-sectional, including retrospective, qualitative, pretest–posttest, systematic reviews, meta-analyses, randomized controlled trials, cohort studies, and case–control studies
4.
Inclusion of studies evaluating vaccine hesitancy without specifying the vaccines involved, considering them as part of the WHO-recommended routine immunization schedule
4. Studies assessing the VH indicator before and after a specific incident
5.
Studies employing a cross-sectional design or mixed-methods design with a cross-sectional component
5. Studies lacking a general vaccine hesitancy (VH) indicator
6.
No restriction by the year of publication
6. Studies that assessed VH for only one type of vaccine
7.
Studies exclusively using validated scales to assess parental childhood vaccine hesitancy
7. Studies in which it was impossible to calculate the absolute value of the indicator for the sample
8. Studies that examined hesitancy in the entire population regarding vaccination in general (except when focused on parents)
9. Studies involving parents of children with chronic disorders
10. Studies that examined hesitancy regarding immunization programs with specific characteristics (mumps, seasonal influenza, and varicella)
11. Studies involving parents of children aged 7 years and older
12. Studies that examined vaccine hesitancy for high-risk populations (typhoid, hepatitis A, dengue, etc.)
13. Studies for populations of specific regions (Japanese encephalitis, yellow fever, tick-borne encephalitis), as well as for HPV and COVID-19 vaccines.
Table 2. Summarized characteristics of included studies.
Table 2. Summarized characteristics of included studies.
NumberReferenceCountryWHO RegionIncome LevelStudy PeriodType of StudySample SizePopulationData Collection ToolHesitancy,
n (%)		Refusal/Delay, n (%)Quality
(JBI)
1Bianco et al. (2019) [29]ItalyEuropean RegionHigh incomeFrom April to June 2017Cross-sectional study575 parents Parents having at least one child aged 1–5 yearsParent Attitudes about Childhood Vaccines (PACV) scale44 (7.7%) 141 (24.6%) High (7)
2Sahoo et al. (2023) [30]India South-East Asia RegionLower middle incomeFrom March to May 2019 Cross-sectional study196 caregiversСaregivers of children aged 6 months to below 5 yearsWHO SAGE 10-item Vaccine Hesitancy Scale for assessing parental attitude towards childhood vaccines (PACV); a scale for measuring “belief toward vaccines”18 (9.18%);
6 months to 1 year—10 (16.9%);
1–2 years—5 (6.2%);
2–5 years—3 (5.4%)		N/AHigh (9)
3Williams et al. (2021) [32]USARegion of the AmericasHigh incomeAugust 2019
through February 2020		Cross-sectional study263 parents English- and Spanish-speaking parents of children aged 2 yearsParent Attitudes about Childhood Vaccines (PACV) scale33 (13%);
4 (4%) Spanish-speaking parents were hesitant versus 29 (19%) English-speaking parents 		N/AHigh (7)
4E. Dubé et al. (2019) [33]CanadaRegion of the AmericasHigh incomeDuring the period of March 2014 to February 2015Cross-sectional study2645 mothers
of newborns		Mothers of newborns (2 months of age)Parent Attitudes about Childhood Vaccines (PACV) scale1492 (56.4%) ((397 (15.0%) mothers had a score of 50 and higher (high level of VH))N/AHigh (7)
5F. Ustuner Top et al. (2023) [34]TurkeyEuropean RegionUpper middle incomeImplemented online between July 2021 and October 2021Cross-sectional study582 parentsParents with children aged 3–5 years oldParent Attitudes about Childhood Vaccines (PACV) scale182 (31.3%)
(3 years—79 (31.9%);
4 years—51 (29.8%);
5 years—52 (31.9%))		N/AHigh (8)
6Thapar et al. (2021) [31]IndiaSouth-East Asia RegionLower middle incomeDuring the months of March and April 2017Cross-sectional study172 mothersMothers of under-five childrenParent Attitudes about Childhood Vaccines (PACV) scale6 (3.4%)13 (7.6%)High (9)
7S. Yoruk et al. (2021) [35]TurkeyEuropean RegionUpper middle incomeSeptember–December 2020Cross-sectional study370 parentsParents of children between 12 months and 6 years oldParent Attitudes about Childhood Vaccines (PACV) scale51 (13.8%);
0–24 months—27 (12.4%);
25–59 months—24 (15.7%) 		18 (4.8%)High (9)
8Durmaz et al. (2022) [36]TurkeyEuropean RegionUpper middle incomeBetween September and December 2021Cross-sectional study1087 parentsParents of children aged 0–60 monthsParent Attitudes about Childhood Vaccines (PACV) scale102 (9.38%)N/AHigh (8)
9Hadjipanayis et al. (2020) [45]18 European countries: Austria, Bulgaria, Croatia, Cyprus, Germany, Greece, Hungary, Israel, Italy, Lithuania, Malta, Moldova, the Netherlands, Poland, Portugal, Slovenia, Spain, UkraineEuropean RegionHigh income: Austria, Croatia, Cyprus, Germany, Greece, Hungary, Israel, Italy, Lithuania, Malta, the Netherlands, Poland, Portugal, Slovenia, Spain;
upper middle income:
Bulgaria, Moldova;
lower middle income:
Ukraine		N/AMixed study 5736 parents;
European countries:
Austria (n = 368), Bulgaria (n = 479), Croatia (n = 334), Cyprus (n = 463), Germany (n = 256), Greece (n = 210), Hungary (n = 350), Israel (n = 194), Italy (n = 413), Lithuania (n = 318), Malta (n = 201), Moldova (n = 256), the Netherlands (n = 413), Poland (n = 443), Portugal (n = 243), Slovenia (n = 99), Spain (n = 318), Ukraine (n = 372)		Parents having at least one child 1 to 4 years of age, living in one of the participating eighteen European countriesQuestionnaire was developed by the European Academy of Paediatrics Research in Ambulatory Setting Network (EAPRASnet) steering committee, based on two sources: PACV and WHO SAGE VHS. Most of the items were taken from PACV, and a minority from the WHO SAGE recommendations24% of 5736 respondents defined themselves as “somewhat hesitant” and 4% as “very hesitant”.
European countries:
Austria 121 (33%), Bulgaria 167 (35%), Croatia 77 (23%), Cyprus 65 (14%), Germany 66 (26%), Greece 69 (33%), Hungary 73 (21%), Israel 81 (42%), Italy 148 (36%), Lithuania 121 (38%), Malta 28 (14%), Moldova 66 (26%), the Netherlands 78 (19%), Poland 181 (41%), Portugal 22 (9%), Slovenia 24 (24%), Spain 54 (17%), Ukraine 149 (40%)		N/AHigh (9)
10Khattak et al. (2021) [37]PakistanEastern Mediterranean RegionLower middle incomeFrom March to July 2019Cross-sectional study 610 parentsParents with children aged 0–59 months WHO SAGE Vaccine Hesitancy toolN/A170 (27.9%) refusers High (9)
11Goruntla et al. (2023) [38]IndiaSouth-East Asia RegionLower middle incomeFrom July to December 2021Cross-sectional study574 respondents Mothers of children under 5 years oldWHO SAGE Vaccine Hesitancy tool 161 (28.05%)161 mothers (refusal = 7; delay = 154)High (9)
12Ghosh et al. (2022) [39]IndiaSouth-East Asia RegionLower middle incomeFrom June 2018 to November 2019Cross-sectional study1678 caregivers
Caregivers of children aged 1–5 years WHO SAGE Vaccine Hesitancy tool698 parents (41.6%)
(˂24 months—225 (41.4%);
24–47 months—196 (47.5%);
˃47 months—277 (38.4%))		N/AHigh (8)
13Yakum et al. (2022) [40]CameroonAfrican RegionLower middle incomeNovember 2021Cross-sectional study529 parents/guardiansParents/guardians of children aged 0–59 monthsWHO SAGE Vaccine Hesitancy tool137 (25%) (without yellow fever vaccine 125 (23.6%))N/AHigh (8)
14Masters et al. (2018) [41]EthiopiaAfrican RegionLow income1–21 June 2017Cross-sectional study350 caregivers Caregivers of children aged 3 to 12 monthsWHO SAGE Vaccine Hesitancy tool12 (3.44%)13 (3.74%)High (8)
15Wang et al. (2022) [52]ChinaWestern Pacific RegionUpper middle incomeFrom September to October 2020,
February to March 2021, May to June 2021		Three waves of cross-sectional studies2881/1038/1183 parentsParents of children aged ≤ 6 yearsSelf-administered questionnaire with WHO SAGE Vaccine Hesitancy tool225/2881 (7.8%),
157/1038 (15.1%),
65/1183 (5.5%)		N/AHigh (7)
16Bocquier et al. (2018) [43]FranceEuropean RegionHigh incomeBetween January and July 2016Cross-sectional telephone survey3927 parents (1268 (32%) parents of children aged 3 or younger)Parents of children aged 1–15 years Three questions adapted from the SAGE group’s definition of VHN/ARefusers = 1090 (26%);
Delayers = 272 (7%)
(among parents of children aged 3 or younger:
Refusers = 270 (21.3%);
Delayers = 95 (7.4%)) *		High (8)
17Migriño et al. (2020) [44]PhilippinesWestern Pacific RegionLower middle incomeN/ACross-sectional study110 respondentsParents and caregivers of
at least one child 2 years old or younger 		A modified questionnaire adapted from the SAGE
Working Group on Vaccine Hesitancy		40 (36.4%) N/AHigh (8)
18Neto et al. (2023) [46]BrazilRegion of the AmericasUpper middle incomeFrom January 2018 to December 2019Cross-sectional study1261 parentsParents of children aged up to 72 monthsSelf-administered questionnaire63 (5%)N/AHigh (8)
19Campbell et al. (2017) [47]EnglandEuropean RegionHigh incomeBetween January and April 2015Cross-sectional study1792 parents
(0–2 years = 1130;
3–4 = 999;
both ages = 337)		Primary caregivers of children aged from 2 months to ˂5 yearsSelf-administered questionnaire using computer-assisted personal interviewingN/ARefusers = 43 (2%);
Delayers = 125 (7%) *		High (8)
20Cherian et al. (2022) [48]IndiaSouth-East Asia RegionLower middle incomeFrom November 2015 to April 2017Cross-sectional study350 caregiversCaregivers of children aged 13–24 monthsSelf-structured questionnaire101 (28.9%)N/AHigh (8)
21Giambi et al. (2017) [49]ItalyEuropean RegionHigh incomeIn the period December 2015–June 2016Cross-sectional study3130 parents Parents of children aged 16–36 monthsSelf-structured questionnaire448 (15.6%)N/AHigh (9)
22Voo et al. (2021) [50]MalaysiaWestern Pacific RegionUpper middle incomeFrom February to March 2018Cross-sectional study405 parentsParents of children aged 0–4 yearsSelf-administered questionnaire27 (6.8%)N/AHigh (9)
23Brown et al. (2018) [51]BrazilRegion of the AmericasUpper middle incomeBetween February and July 2016Cross-sectional study
(online and face-to-face interviews) 		952 parents (352 parents of children aged ≤ 5 years)Parents of children aged ≤ 5 years Vaccine Confidence Index (VCI) questionnaireOverall VH = 16.5% (n = 157). Of the 352 parents of children aged ≤ 5 years, 75 (21.3%) reported VHOverall refusal rate = 4.5% (n = 43). Of the 352 parents of children aged ≤ 5 years, 6 (1.7%) refused vaccineHigh (8)
* Absolute values were calculated based on the percentage of the final VH result. N/A—Not Applicable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Abenova, M.; Shaltynov, A.; Jamedinova, U.; Semenova, Y. Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0–6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies. Vaccines 2024, 12, 31. https://doi.org/10.3390/vaccines12010031

AMA Style

Abenova M, Shaltynov A, Jamedinova U, Semenova Y. Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0–6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies. Vaccines. 2024; 12(1):31. https://doi.org/10.3390/vaccines12010031

Chicago/Turabian Style

Abenova, Madina, Askhat Shaltynov, Ulzhan Jamedinova, and Yuliya Semenova. 2024. "Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0–6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies" Vaccines 12, no. 1: 31. https://doi.org/10.3390/vaccines12010031

APA Style

Abenova, M., Shaltynov, A., Jamedinova, U., & Semenova, Y. (2024). Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0–6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies. Vaccines, 12(1), 31. https://doi.org/10.3390/vaccines12010031

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop